---
figid: PMC8001359__cancers-13-01236-g009
figtitle: ISL effect on TGFB1 induced epithelial-mesenchymal transition (EMT) in human
  endometrial cancer
organisms:
- NA
pmcid: PMC8001359
filename: cancers-13-01236-g009.jpg
figlink: pmc/articles/PMC8001359/figure/cancers-13-01236-f009/
number: F9
caption: 'Schematic diagram of ISL effect on TGF-β1 induced epithelial-mesenchymal
  transition (EMT) in human endometrial cancer. (1) ISL arrests the EMT progress via
  decreasing cells migration ability. (2,3) ISL reduces p-Smad3 expression and prevents
  its translocating into the nucleus and subsequent binding with TWIST1/2 (transcription
  factor) to regulate target gene expression. (4–5) ISL reverses the effect of TGF-β
  by restoring the loss on the epithelial marker (E-cadherin) and revoking the gain
  of mesenchymal markers (N-cadherin, vimentin, and α-SMA). Abbreviation: transforming
  growth factor beta (TGF-β); epithelial–mesenchymal transition (EMT).'
papertitle: Isoliquiritigenin Reverses Epithelial-Mesenchymal Transition Through Modulation
  of the TGF-β/Smad Signaling Pathway in Endometrial Cancer.
reftext: Hsin-Yuan Chen, et al. Cancers (Basel). 2021 Mar;13(6):1236.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9645176
figid_alias: PMC8001359__F9
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8001359__F9
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8001359__cancers-13-01236-g009.html
  '@type': Dataset
  description: 'Schematic diagram of ISL effect on TGF-β1 induced epithelial-mesenchymal
    transition (EMT) in human endometrial cancer. (1) ISL arrests the EMT progress
    via decreasing cells migration ability. (2,3) ISL reduces p-Smad3 expression and
    prevents its translocating into the nucleus and subsequent binding with TWIST1/2
    (transcription factor) to regulate target gene expression. (4–5) ISL reverses
    the effect of TGF-β by restoring the loss on the epithelial marker (E-cadherin)
    and revoking the gain of mesenchymal markers (N-cadherin, vimentin, and α-SMA).
    Abbreviation: transforming growth factor beta (TGF-β); epithelial–mesenchymal
    transition (EMT).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CDH2
  - CDH1
  - FZR1
  - ACTA1
  - ITK
  - SLC22A3
  - TGFB1
  - TGFBR2
  - TGFBR1
  - TGFBR3
  - SMAD2
  - SMAD3
  - SMAD4
  - SNAI1
  - SNAI2
  - SNAI3
  - ZEB1
  - Isoliquiritigenin
---
